Company & Sponsor Intelligence
National Institutes of Health Clinical Center (CC)
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed2
Countries1
Therapeutic footprint
depressionout_of_scope
Indexed studies
NCT01692236Brain Imaging for HIV-Associated Thinking and Mood Disorders
depression · United StatesTERMINATED
depression · United StatesTERMINATED
NCT03831971The Influence of ANS-6637 on Midazolam Pharmacokinetics in Healthy Volunteers
out_of_scope · United StatesPHASE1
out_of_scope · United StatesPHASE1
NCT00006395Drug Interaction Study of Tegretol (Carbamazepine) and St. John's Wort in Normal Volunteers
out_of_scope · United StatesPHASE4
out_of_scope · United StatesPHASE4
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →